Brain Sentinel Announces Business Partnership with Academy Medical to Bring Breakthrough SPEAC® System Seizure Monitor to Active and Retired Military with Epilepsy

The SPEAC System Helps Patients and Their Seizures Be Heard

With the vast majority of epilepsy care delivered in the home, the SPEAC® System is uniquely positioned to help neurologists better help those who have served our country.

Brain Sentinel, Inc., manufacturer of the novel SPEAC® System, proudly announces its entrance into the military healthcare market with the launch of its exclusive, federal, distribution partnership with Academy Medical LLC , a certified Service-Disabled Veteran-Owned Small Business. The partnership makes the SPEAC® System, a recently FDA-cleared Seizure Monitoring and Alerting System, available to the Department of Veterans Affairs (VA), Department of Defense (DoD), and Indian Health Services (IHS) medical treatment facilities. The SPEAC® System is the first FDA-cleared, non-EEG, physiological, signal-based system for seizure monitoring.

“The VA has recognized that uncontrolled epilepsy is a problem within the military”, said Mike Girouard, President, CEO and Cofounder of Brain Sentinel, Inc. According to the 2016 Epilepsy Centers of Excellence Annual Report, the VA reported that


  • 83,362 veterans sought care for their epilepsy in 2015, 1.3% of all VA patients
  • The prevalence of epilepsy in the VA population is 13.8 per 1,000 patients
  • 843 patients were admitted for long-term monitoring

Girouard continued, “We are excited to partner with Academy Medical to bring a new diagnostic tool to the VA medical community. Academy is a recognized leader in bringing novel medical technologies to those serving or who have served our country. With the vast majority of epilepsy care delivered in the home, the SPEAC® System is uniquely positioned to help neurologists better help those who have served our country.”

“We are excited about the opportunity to expand our portfolio and offerings into the government channel by affiliating with Brain Sentinel,” said Dan Shaw, President, Academy Medical. “We have been working on this partnership for some time and are looking forward to this long lasting mutually beneficial relationship.”

About the SPEAC® System

On February 16, 2017, Brain Sentinel received US Food and Drug Administration (FDA) de novo clearance to begin…

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *